SCHEMBL8699187

SCHEMBL8699187

O=C(NC(Cc1ccccc1)C(=O)C(=O)O)OCc1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 2/20 0.65
CTSL P07711 2/20 0.64
CTSB P07858 2/20 0.64
CTSS P25774 2/20 0.64
CTSK P43235 2/20 0.64
ALDH1A1 P00352 1/20 0.62
ALOX15 P16050 1/20 0.62
CTRB1 P17538 2/20 0.61
CAPN1 P07384 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ether SCHEMBL8696645 0.92 CTSL (0.59) TACR1CTSLCTSBCTSSCTSK
SCHEMBL29550348 0.90 TACR1 (0.64) TACR1CTSLCTSBCTSSCTSK
SCHEMBL8701970 0.88 ALDH1A1 (0.67) TACR1CTSLCTSBCTSSCTSK
SCHEMBL13296495 0.88 CAPN1 (0.63) TACR1CTSLCTSBCTSSCTSK
SCHEMBL479010 0.88 TACR1 (0.68) TACR1CTSLCTSBCTSSCTSK
SCHEMBL26661077 0.88 TACR1 (0.68) TACR1CTSLCTSBCTSSCTSK
SCHEMBL7372270 0.88 TACR1 (0.68) TACR1CTSLCTSBCTSSCTSK
SCHEMBL15080871 0.88 TACR1 (0.68) TACR1CTSLCTSBCTSSCTSK
SCHEMBL220648 0.88 TACR1 (0.68) TACR1CTSLCTSBCTSSCTSK
SCHEMBL219151 0.88 TACR1 (0.68) TACR1CTSLCTSBCTSSCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5736520-A INHIBITING CALPAIN BY ADMINISTERING A DIPEPTIDE OF THE FORMULA BENZYLCARBONYLOXYVAL-NH-CH(-R2)-CHO WHERE R2 IS THE SIDE CHAIN OF PHE; ANTICARCINOGENIC,-ARTHRITIC AND CARDIOTONIC AGENTS; COAGULANTS; STROKE MERRELL PHARMACEUTICALS INC. (US) 1998-04-07 US disclosed
EP-0363284-A2 Use of peptidase inhibitors for the preparation of medicaments useful for the treatment of strokes MERRELL PHARMACEUTICALS INC. (US) 1990-04-11 EP disclosed